Metastatic Brain Tumors
- Metastatic brain tumors (also called secondary brain tumors) are caused by cancer cells spreading (metastasizing) to the brain from a different part of the body.
- The cancer cells break away from the primary tumor and travel to the brain, usually through the bloodstream, then commonly go to the part of the brain called the cerebral hemispheres or to the cerebellum. Cancer can also spread to the spine (metastatic spine tumors).
- Metastatic brain tumors are five times more common than primary brain tumors (those that originate in the brain).
- Metastatic brain tumors can grow rapidly, crowding or destroying nearby brain tissue. Sometimes a patient may have multiple metastatic tumors in several different areas of the brain.
What happens when cancer spreads to the brain?
Some metastatic brain tumors appear many years after the primary cancer. Others metastasize so quickly that they are identified before the primary cancer.
In other cases, the body is able to destroy the primary cancer but not the metastatic brain tumor. When this occurs, the primary cancer can be unknown.
Metastatic Brain Tumor: 6 Things You Need to Know
If you or someone you love has a metastatic brain tumor, you’ll want these basics for what lies ahead.
What are the signs and symptoms of metastatic brain tumor?
Common signs and symptoms
Weakness in the arms or legs
Loss of balance
Behavior and personality changes
Blurred vision/vision disturbance
What are the risk factors for metastatic brain tumor?
About one third of patients with another type of cancer will develop one or more metastatic brain tumors. The risk for metastatic brain tumors begins to increase after age 45 and is highest in those over 65.
Metastatic Brain Tumors: Q&A with a Neurosurgeon
Johns Hopkins neurosurgeon Michael Lim, M.D., says every brain tumor — and every patient — is unique. Find out more about his approach to treating brain tumors.
How are metastatic brain tumors diagnosed?
Metastatic brain and spine tumors are not usually diagnosed until symptoms appear. Here are some ways doctors may diagnose a metastatic brain tumor:
Physical exam: After gathering information about your symptoms and personal and family health history, the doctor proceeds with a physical exam and vision and reflex tests.
Computed tomography (CT or CAT scan)
Diffusion tensor imaging (DTI): This scan allows the surgeon and treating team to visualize the circuitry (or wiring) of the brain to guide the surgery. These images can then be loaded into navigation systems that are used in the operating room to serve as a kind of GPS and map for the surgeon.
Infographic: Advancements in Brain Tumor Treatment
Brain tumor treatment continues to evolve with new techniques and technologies, and your doctor has more options than ever to choose from when designing your individualized treatment plan. Here’s a quick look at some newer developments that may improve the outlook for those living with brain tumors.
Metastatic Brain Tumor Treatment
It is important to know that metastatic brain tumors are often treatable and can be well controlled.
Optimal treatment for metastatic brain or spine tumors is tailored to each patient. The neurosurgeon determines the most appropriate treatment approach, considering these factors:
The type of primary cancer the patient has, response to treatment and current status
The location and number of metastatic tumors within the brain or spine
The patient’s general health and preferences regarding potential treatment options
The patient's current symptoms
Surgery provides fast relief of “mass effect” — pressure inside the skull resulting from a growing tumor and swelling of the brain. Patients can experience improvement within hours of surgery if mass effect is what is causing their symptoms.
The goal of surgery is to minimize the amount of space the tumor takes up by debulking, removing as much of the tumor as possible while maintaining the patient’s neurological function.
In general, doctors recommend surgery when:
There is a clear correlation of neurologic deficits with the tumor’s location
The patient’s primary cancer is treatable and under control
A patient has one or two metastatic brain tumors, or a few tumors that are close to each other that can be safely removed
The surgeon may choose a microsurgery procedure, and use newer tools — such as image-guided surgery and minimally invasive endoscopy — to ensure the best chance for a good outcome.
Radiation therapy is the treatment of tumors using X-rays and other forms of radiation (light energy) to destroy cancer cells or prevent a tumor from growing. It is also called radiotherapy.
These painless treatments involve passing beams of radiation through the body, which can treat cancers in areas of the brain that are difficult to reach through surgery. Procedures may include any one or combination of the following:
Stereotactic radiosurgery (e.g., fractionated radiosurgery)
These procedures may also be performed after surgery to prevent tumors from growing near the site of the tumor removal and into other brain tissue.
Choosing radiation therapy is complex and often involves a team approach. Some patients receive a form of radiation therapy called stereotactic radiosurgery instead of surgery. Other patients will receive whole-brain radiation or a combination of both therapies, depending on what the treatment team determines is best.
The Radiation Team
Treatment planning for radiation therapy includes mapping to pinpoint the exact location of the tumor using X-rays or other images.
A radiation oncologist uses these images to create a three-dimensional picture of the patient’s brain. For some types of radiation therapy, a custom-fitted mask is created to increase the precision of the treatment. Fiducials — small markers temporarily attached to the scalp — may also be used.
A radiation oncologist then designs the patient’s treatment, determining the most appropriate radiation dose (the level of radiation energy to be used) and delivery method.
A dosimetrist or medical physicist (professionals who specialize in using radiation therapy equipment and calculating and measuring radiation) will calculate the dose, the angle of the treatment beam and the amount of time for each beam. After they work with the radiation oncologist to review the calculations, the treatments can be scheduled.
Radiation Therapy for a Metastatic Brain Tumor: 3 Things You Should Know
If you need radiation therapy, you may be worried about side effects. It’s one of the most common concerns that Johns Hopkins neurosurgeon Michael Lim, M.D., hears from patients with metastatic brain tumors. Here’s what he wants you to know.
Because traditional chemotherapy cannot cross the blood-brain barrier, a new treatment called targeted therapy is used as the primary type of chemotherapy for treating metastatic brain tumors.
These drugs identify and attack cancer cells (the target) with minimal harm to normal cells while preventing the growth and spread of cancer cells. Targeted therapy can be administered after surgery or in conjunction with radiation therapy to destroy remaining cancer cells.
Targeted therapies used to treat metastatic brain tumors include:
Trastuzumab for breast cancer that has metastasized to the brain
Erlotinib for the most common type of lung cancer (non-small cell lung cancer) that has metastasized to the brain
Cancer immunotherapy is a fast-growing field of research that seeks to develop drugs, vaccines and other therapies that trigger the immune system’s natural abilities to fight cancer.
Clinical trials for new treatments
Researchers are always finding new ways to treat metastatic brain tumors. These new methods are tested in clinical trials. Talk with your healthcare provider to find out if there are any clinical trials you should consider.
Your thoughts matter to us. Join our community today.
Johns Hopkins Medicine Virtual Advisors (Virtual Advisors) is a group of individuals who share their insights about the Johns Hopkins care experience. One to two times per month, Virtual Advisors receive a link to short, interactive surveys. All responses are confidential.